M. avium binding to HLA-DR expressed alleles in silico: A model of phenotypic susceptibility to sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 25, Issue 2, 2008, Pages 100-116

  Saltini, C ^a   Pallante, M ^a   Puxeddu, E ^a   Contini, S ^a   Voorter, C E ^b,c   Drent, M ^c   Amicosante, Massimo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic sarcoidosis; Epitope prediction; HLA DR; L fgren's syndrome; Susceptibility; T cell response; Tuberculosis

Indexed keywords

EPITOPE; HLA DR ANTIGEN;

ALLELE; ANTIGEN BINDING; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIAL GENOME; BIOINFORMATICS; CHRONIC DISEASE; COMPUTER MODEL; CONTROLLED STUDY; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GRANULOMATOUS INFLAMMATION; HUMAN; LOFGREN SYNDROME; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SARCOIDOSIS;

ALLELES; BINDING SITES, ANTIBODY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; MYCOBACTERIUM AVIUM; PHENOTYPE; SARCOIDOSIS;

EID: 62549109949     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Crystal RG, Roberts WC, Hunninghake GW, Gadek JE, Fulmer JD, Line BR. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes. Ann Intern Med 1981; 94: 73-94.
2. Venet A, Hance AJ, Saltini C, Robinson BWS, Crystal RJ. Enhanced Alveolar Macrophage-mediated Antigen-induced T Lymphocyte Proliferation in Sarcoidosis. J Clin Invest 1985; 75: 293-301.
3. Spurzem JR, Saltini C, Kirby M, Konishi K, Crystal RG. Expression of HLA class II genes in alveolar macrophages of patients with sarcoidosis. Am Rev Respir Dis 1989; 140: 89-94.
4. Pinkston P, Bitterman PB, Crystal RG. Spontaneous release of interleukin-2 by lung T-lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983; 308: 793-800.
5. Saltini C, Spurzem JR, Lee JJ, Pinkston P, Crystal RG. Spontaneous Release of Interleukin 2 by Lung T Lymphocytes in Active Pulmonary Sarcoidosis Is Primarily from the Leu3+DR+ T Cell Subset. J Clin Invest 1986; 77: 1962-70.
6. du Bois RM, Kirby M, Balbi B, Saltini C, Crystal RG: T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the T-cell antigen receptor. Am Rev Respir Dis 1992; 154: 1205-11.
7. Saltini C, Kirby M, Trapnell BC, Tamura N, Crystal RG. Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J Exp Med 1990; 171: 1123-40.
8. Silver RF, Crystal RG, Moller DR. Limited heterogeneity of biased T-cell receptor Vβ gene usage in lung but not blood T cells in active pulmonary sarcoidosis. Immunology 1996; 88: 516-23.
9. Moller DR. T-cell receptor genes in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15: 158-64.
10. Thomeer M, Demedts M, Wuyts W. Epidemiology of sarcoidosis. In: Dent M, Costabel U, eds. Sarcoidosis Eur Respir Mon 2005; 32: 13-22.
11. Saltini C, Winestock K, Kirby M, Pinkston P, Crystal RG. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T-cells. N Engl J Med.1989; 320: 1103-9.
12. Redline S, Barna B, Tomashefski JF, Abraham JL. Granulomatous disease associated with pulmonary deposition of titanium. Br J Indust Med 1986; 43: 652-6.
13. Werfel U, Schneider J, Rödelsperger K, et al. Sarcoid granulomatosis after zirconium exposure with multiple organ involvement. Eur Respir J 1998; 12: 750.
14. De Vuyst P, Dumortier P, Schandené L, Estenne M, Verhest A, Yernault JC. Sarcoidlike lung granulomatosis induced by aluminum dusts. Am Rev Respir Dis 1987; 135: 493-7.
15. Hanak V, Kalra S, Timothy R, et al. Hot tub lung: Presenting features and clinical course of 21 patients. Respiratory Medicine 2006; 100: 610-5.
16. Hodgson MJ, Bracker A, Yang C, et al. Hypersensitivity Pneumonitis In a Metal-Working Environment. American J Industrial Medicine 2001; 39: 616-28.
17. Sechi LA, Scanu AM, Molicotti P, et al. Detection and Isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn's disease in Sardinia. Am J Gastroenterol 2005; 100: 1529-36.
18. Brisson-Noöel A, Gicquel B, Lecossier D, Lévy-Frébault V, Nassif X, Hance AJ. Rapid diagnosis of tuberculosis by amplification of mycobacterial DNA in clinical samples. Lancet 1989; 2: 1069-71.
19. Bocart D, Lecossier D, De Lassence A, Valeyre D, Battesti JP, Hance AJ. A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction. Am Rev Respir Dis 1992; 145: 1142-8.
20. Saboor SA, Johnson NM, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992; 339: 1012-5.
21. Eishi Y, Suga M, Ishige I, et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 2002; 40: 198-204.
22. Ishige I, Eishi Y, Takemura T, et al. Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 33-42.
23. Ichikawa H, Kataoka M, Hiramatsu J, et al. Quantitative analysis of propionibacterial DNA in bronchoalveolar lavage cells from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25: 15-20.
24. Fidler HM. Mycobacteria and sarcoidosis: recent advances. Sarcoidosis 1994; 11: 66-8.
25. Mangiapan G, Hance AJ. Mycobacteria and sarcoidosis: an overview and summary of recent molecular biological data. Sarcoidosis 1995; 12: 20-37.
26. Gupta D, Agarwal R, Aggarwal AN, Jindal SK. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J 2007; 30: 508-16.
27. Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005, 201: 755-67.
28. Dubaniewicz A, Trzonkowski P, Dubaniewicz-Wybieralska M, Dubaniewicz A, Singh M, Mysliwski A. Mycobacterial heat shock protein-induced blood T lymphocytes subsets and cytokine pattern: comparison of sarcoidosis with tuberculosis and healthy controls. Respirology 2007; 12: 346-54.
29. Hajizadeh R, Sato H, Carlisle J, et al. Mycobacterium tuberculosis Antigen 85A induces Th-1 immune responses in systemic sarcoidosis. J Clin Immunol 2007; 27: 445-54.
30. Drake WP. When a commensal becomes a pathogen. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25: 10-11.
31. Moller DR. State of the Art. Potential Etiologic Agents in Sarcoidosis. The Proceedings of the American Thoracic Society 2007; 4: 465-8.
32. Tercelj M, Salobir B, Rylander R. Microbial antigen treatment in sarcoidosis a new paradigm? Med Hypotheses 2008; 70: 831-4.
33. Davenport MP, Quinn CL, Valsasnini P, Sinigaglia F, Hill AV, Bell JI. Analysis of peptide-binding motifs for two disease associated HLA-DR13 alleles using an M13 phage display library. Immunology 1996; 88: 482-6.
34. Mallios RR. Predicting class II MHC/peptide multi-level binding with an iterative stepwise discriminant analysis meta-algorithm. Bioinformatics 2001; 17: 942-8.
35. Voorter CE, Amicosante M, Berretta F, Groeneveld L, Drent M, van den Berg-Loonen EM. HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens 2007; 70: 18-27.
36. Rossman MD, Thompson B, Frederick M, et al: HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003; 73: 720-35.
37. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997; 156: 1601-5.
38. Grunewald J, Eklund A. Sex-specific manifestations of Lofgren's syndrome. Am J Respir Crit Care Med 2007; 175: 40-4.
39. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994; 76: 287-99.
40. Sturniolo T, Bono E, Ding J, et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 1999; 17: 555-61.
41. Scherer A, Frater J, Oxenius A, et al. Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS. Proc Natl Acad Sci USA 2004; 101: 12266-70.
42. Stunz L, Karr RW, Anderson R. HLA-DRB1 and -DRB4 genes are differentially regulated at the transcriptional level. J Immunol 1989; 143: 3081-6.
43. Berdoz J, Gorski J, Termijtelen A, et al. Constitutive and induced expression of the individual HLA-DR h and a chain loci in different cell types. J Immunol 1987; 139: 1336-41.
44. Cotner T, Charbonneau H, Mellins E, Pious D. mRNA abundance, rather than differences in subunit assembly, determine expression of HLA-DRh1 and DRh3 molecules. J Biol Chem 1996; 264: 11107-11.
45. De Groot AS, Bosma A, Chinai N, et al. From genome to vaccine: in silico predictions, ex vivo verification. Vaccine 2001; 19: 4385-95.
46. Contini S, Pallante M, Vejbaesya S, et al. A model of phenotypic susceptibility to Tuberculosis: deficient in silico selection of Mycobacterium tuberculosis epitopes by HLA alleles. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25: 21-8.
47. Marsh SGE. Nomenclature for factors of the HLA system, update January 1998. Tissue Antigens 1998; 51: 582-3.
48. Marsh SG. WHO Nomenclature Committee for Factors of the HLA System. Nomenclature for factors of the HLA system, update September 2006. Tissue Antigens 2006; 68: 540-2.
49. Kubo K, Yamazaki Y, Hanaoka M, et al. Analysis of HLA antigens in Mycobacterium avium-intracellulare pulmonary infection. Am J Respir Crit Care Med 2000; 161: 1368-71.
50. Singh H, Raghava GP. ProPred: prediction of HLA-DR binding sites. Bioinformatics 2001; 17: 1236-7.
51. Grosser M, Luther T, Fuessel M, Bickhardt J, Magdolen V, Baretton G. Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments. Sarcoidosis Vasc Diffuse Lung Dis 2005, 22: 66-74.
52. Moller DR, Chen ES. Genetic basis of remitting sarcoidosis. Triumph of the trimolecular complex? Am J Respir Cell Mol Biol 2002; 27: 391-5.
53. Lenzini L, Rottoli P, Rottoli L. The spectrum of human tuberculosis. Clin exp Immunol 1977; 27: 230-7.
54. Soebono H, Giphart MJ, Schreuder GM, Klatser PR, de Vries RR. Associations between HLA-DRB1 alleles and leprosy in an Indonesian population. Int J Lepr Other Mycobact Dis 1997; 65: 190-6.
55. Rani R, Fernandez-Vina MA, Zaheer SA, Beena KR, Stastny P. Study of HLA class II alleles by PCR oligotyping in leprosy patients from north India. Tissue Antigens 1993; 42: 133-7.
56. De Vries RPP. An immunogenetic view of delayed type hypersensitivity. Tubercle 1991; 72: 161-7.